Erenumab (Aimovig) for migraine prevention.
Med Lett Drugs Ther
; 60(1549): 101-103, 2018 06 18.
Article
in En
| MEDLINE
| ID: mdl-29913472
Key words
Aimovig; Botox; Corgard; Cymbalta; Depakote; Effexor; Epival; Inderal; Lixiana; Lopresor; Lopressor; Qudexy; SNRIs; Tenormin; Topamax; Trokendi; adverse effects; amitriptyline; antiepileptics; atenolol; beta blockers; botulinum toxin; dosage; duloxetine; efficacy; erenumab; metoprolol; migraine; nadolol; onabotulinumtoxinA; pregnancy; propranolol; safety; timolol; topiramate; tricyclic antidepressants; valproate; venlafaxine
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Migraine Disorders
/
Antibodies, Monoclonal
Type of study:
Clinical_trials
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Med Lett Drugs Ther
Year:
2018
Document type:
Article
Country of publication:
Estados Unidos